Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Castration effects on tumor-specific immunity

G E Brannen

    National Cancer Institute Monograph
    |December 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Castration may enhance tumor growth rate but does not affect tumor-specific immunity in mice. This study explored host-tumor immunorelationships relevant to endocrine therapy for prostate cancer.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Endopyelotomy: review of results and complications.

    The Journal of urology·1991
    Same author

    Pulsed dye laser fragmentation of ureteral calculi: a review of the first 50 cases performed at Virginia Mason Medical Center.

    The Journal of urology·1990
    Same author

    Injectable internal ureteral stent.

    Urology·1990
    Same author

    Suppressed antidonor MLC responses in renal transplant candidates conditioned with donor-specific transfusions that carry the recipient's noninherited maternal HLA haplotype.

    Transplantation·1990
    Same author

    Ureteropelvic junction obstruction: treatment with percutaneous endopyelotomy.

    Radiology·1989
    Same author

    Total prostatectomy for clinically localized prostatic cancer: long-term results.

    The Journal of urology·1989
    Same journal

    Forty-five years of cancer incidence in Connecticut: 1935-79.

    National Cancer Institute monograph·1986
    Same journal

    Second cancer following cancer of the breast in Connecticut, 1935-82.

    National Cancer Institute monograph·1985
    Same journal

    Second cancer following cancer of the respiratory system in Connecticut, 1935-1982.

    National Cancer Institute monograph·1985
    Same journal

    Second cancer following cancer of the digestive system in Connecticut, 1935-82.

    National Cancer Institute monograph·1985
    Same journal

    Summary: multiple primary cancers in Denmark, 1943-80.

    National Cancer Institute monograph·1985
    Same journal

    Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-80.

    National Cancer Institute monograph·1985
    See all related articles

    Area of Science:

    • Immunology
    • Oncology
    • Endocrinology

    Background:

    • The relationship between hormonal status and tumor immunity is complex.
    • Endocrine therapy is a key treatment for prostate adenocarcinoma, but its immunomodulatory effects require further investigation.

    Purpose of the Study:

    • To investigate the impact of castration on tumor growth rate and tumor-specific transplantation immunity.
    • To explore the mechanisms of host-tumor immunorelationships in the context of endocrine therapy.

    Main Methods:

    • Utilized 3-methylcholanthrene-induced fibrosarcomas in CD2F1 male mice.
    • Conducted tumor transplantation experiments involving over 500 mice.
    • Compared tumor-specific immunoresistance in castrate versus control male mice after tumor excision and subsequent challenge.

    Related Experiment Videos

    Main Results:

    • Castration was observed to potentially enhance the rate of tumor growth.
    • No significant effect of castration on tumor-specific immunoresistance was detected.
    • Tumor growth rate was influenced by castration, but immune resistance remained unaffected.

    Conclusions:

    • Castration influences tumor growth dynamics but not the development of tumor-specific immune resistance.
    • Findings suggest complex host-tumor immunorelationships that may inform endocrine therapy strategies for prostate adenocarcinoma.